Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,895 | -10,610 | -39,772 | -30,205 | -18,957 |
| Depreciation Amortization | 2,020 | 1,013 | 3,943 | 2,894 | 1,932 |
| Income taxes - deferred | 270 | 3 | 15 | -78 | -220 |
| Accounts receivable | -561 | 449 | -1,438 | -215 | -522 |
| Accounts payable and accrued liabilities | 1,334 | 1,304 | 680 | 1,427 | 90 |
| Other Working Capital | -3,879 | -2,657 | 3,684 | 3,416 | -1,380 |
| Other Operating Activity | 2,191 | -231 | 6,880 | 3,836 | 3,987 |
| Operating Cash Flow | $-18,520 | $-10,727 | $-26,007 | $-18,925 | $-15,070 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,996 | 5,996 | -41,006 | -24,771 | -15,019 |
| PPE Investments | -964 | -433 | -1,733 | -1,109 | -733 |
| Purchase Sale Intangibles | N/A | N/A | -1,125 | -1,250 | -1,250 |
| Other Investing Activity | 0 | 0 | -1,125 | -1,250 | -1,250 |
| Investing Cash Flow | $10,032 | $5,563 | $-43,863 | $-27,130 | $-17,002 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,991 | 1,886 | 82,887 | 82,862 | 82,862 |
| Other Financing Activity | -67 | -67 | -300 | -122 | -122 |
| Financing Cash Flow | $1,924 | $1,818 | $82,587 | $82,740 | $82,740 |
| Exchange Rate Effect | 173 | 447 | 179 | 77 | -80 |
| Beginning Cash Position | 19,397 | 19,397 | 6,502 | 6,502 | 6,502 |
| End Cash Position | 13,006 | 16,498 | 19,397 | 43,264 | 57,090 |
| Net Cash Flow | $-6,391 | $-2,899 | $12,895 | $36,763 | $50,588 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,520 | -10,727 | -26,007 | -18,925 | -15,070 |
| Capital Expenditure | -964 | -433 | -1,733 | -1,109 | -733 |
| Free Cash Flow | -19,484 | -11,161 | -27,740 | -20,034 | -15,803 |